The marketing of a disease: female sexual dysfunction

BMJ. 2005 Jan 22;330(7484):192-4. doi: 10.1136/bmj.330.7484.192.

Abstract

The pharmaceutical industry's dreams of making large profits from treating female sexual dysfunction are starting to look like premature speculation

Publication types

  • Review

MeSH terms

  • Conflict of Interest
  • Drug Industry*
  • Female
  • Humans
  • Marketing*
  • Sexual Dysfunction, Physiological / drug therapy*